RGNX REGENXBIO INC
2026Q1 · CUSIP 75901B107 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
176
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
94
Δ whales
-2
Inst. holding value
$348M
New positions
33
Closed positions
30
Price momentum (1Q)
-29.7%
Put / Call
5/6
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q1 | Top 19% | -22.0% | -39.8% |
| 2022Q3 | Top 6% | +4.6% | -5.5% |
| 2022Q1 | Top 13% | +43.8% | +1.2% |
| 2021Q3 | Top 17% | -16.5% | -38.5% |
| 2019Q1 | Top 10% | -16.9% | -18.8% |
| 2018Q3 | Top 8% | -29.4% | -34.1% |
| 2018Q2 | Top 2% | -9.2% | -28.0% |
| 2018Q1 | Top 17% | +35.3% | +22.8% |
Options Sentiment
Put holders
5
QoQ: +1
Call holders
6
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-5.60
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
-44.0%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)